Novo Nordisk A/S
Novo Nordisk A/S (NVO) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
nvo · stock forecast · 39 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 39 Wall Street analysts in the past 3 months
Buy
39 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$54.00
Consensus
$49.50
+15.2% upside
Low
$45.00
Median: $49.5 · Last Close: $42.96
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$49.50
15.2% upside
High Target
$54
25.7%
Low Target
$45
4.7%
Current Price
$42.96
as of today
Based on analyst price targets, the NVO stock price prediction for the next 12 months ranges from $45 to $54. The consensus NVO price forecast of $49.50 implies 15.2% upside from the current price of $42.96.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $41.90 | ↓ 2.46% |
1-day model range: $41.74–$42.06. Peak: $42.06 (-2.46%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $37 | -13.8% |
| 2028 | $34 | -21.6% |
| 2029 | $32 | -26.2% |
| 2030 | $31 | -29.0% |
| 2031 | — | -30.7% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · NVO · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-02 | Goldman Sachs | Downgrade ↓ | Buy→Neutral |
| 2026-02-24 | JP Morgan | Downgrade ↓ | Overweight→Neutral |
| 2025-12-08 | Argus Research | Downgrade ↓ | Buy→Hold |
| 2025-11-28 | Goldman Sachs | Maintains | Buy→Buy |
| 2025-11-25 | BMO Capital | Maintains | Market Perform→Market Perform |
| 2025-11-24 | HSBC | Downgrade ↓ | Buy→Hold |
| 2025-10-14 | BMO Capital | Maintains | Market Perform→Market Perform |
| 2025-10-02 | HSBC | Upgrade ↑ | Hold→Buy |
| 2025-09-29 | Morgan Stanley | Downgrade ↓ | Equal Weight→Underweight |
| 2025-09-17 | Berenberg | Upgrade ↑ | Hold→Buy |
Wall Street analysts have recently issued updated ratings on Novo Nordisk A/S (NVO) stock. Of the recent 138 rating actions, 32 were upgrades and 38 were downgrades. 39 analysts currently cover NVO.
Analyst Recommendation Trends
NVO analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$295.5B
↓ 8.9% YoY
Revenue Next Year
$302.8B
↑ 2.5% YoY
EPS This Year
$21.82
EPS Next Year
$21.77
↓ 0.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast NVO EPS of $21.82 for the current fiscal year, based on estimates from 8 analysts. The NVO revenue forecast is $295.5B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The NVO stock forecast is supported by two independent data sources: analyst consensus ratings from 39 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus NVO price target is $49.50 (+15.2% upside), with an analyst consensus of Buy.
The NVO short-term stock prediction for tomorrow is $41.90 (-2.46%). The NVO stock price prediction for 2027 estimates an average of $37. The NVO stock prediction for 2030 projects a range of $29–$32.
Novo Nordisk A/S trades on NYSE under the ticker NVO. The NVO stock outlook for 2027 is broadly positive, supported by a Buy consensus among 59% of covering analysts.
Frequently asked questions
NVO forecast · 8 questionsAccording to 39 Wall Street analysts, the average 12-month NVO price target is $49.50, with a high forecast of $54.00 and a low of $45.00. The median price target is shown in the chart above when available. This implies +15.2% potential upside from the current price of $42.96.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.